歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > Angiogenesis > CNX-2006

瀏覽歷史

S80307

CNX-2006

源葉(MedMol) ≥98%
  • 英文名:
  • N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-py
  • 別名:
  • CNX 2006,CNX2006
  • CAS號:
  • 1375465-09-0
  • 分子式:
  • C26H27F4N7O2
  • 分子量:
  • 545.53
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S80307-5mg ≥98% ¥890.00元 6 - - - EA 加入購物車
源葉(MedMol) S80307-10mg ≥98% ¥1330.00元 6 - - - EA 加入購物車
源葉(MedMol) S80307-25mg ≥98% ¥2610.00元 5 - - - EA 加入購物車
源葉(MedMol) S80307-50mg ≥98% ¥3810.00元 1 - - - EA 加入購物車
源葉(MedMol) S80307-100mg ≥98% ¥7200.00元 2 - - - EA 加入購物車
源葉(MedMol) S80307-250mg ≥98% ¥14419.00元 2 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.
  • 靶點: CNX-2006 is a mutant-selective and irreversible EGFR inhibitor with an IC50 below 20 nM for EGFRT790M.;EGFR
  • 體外研究:
    CNX-2006 inhibits EGFR-T790M cells growth up to 1000-fold more compared to wild-type EGFR cells. EGFR inhibition is observed in cells harbouring the T790M mutation at IC50 values below 20 nM after 1 hour exposure to the drug. CNX-2006 also significantly reduces the volume of tumor spheres derived from H1975 cells. CNX-2006 exhibits specificity and potent activity against T790M. The drug also shows activity against uncommon EGFR mutations including G719S, L861Q, an exon 19 insertion mutant (I744-K745insKIPVAI), and T854A, but not an exon 20 insertion (H773-V774HVdup). In an in vitro resistance model, CNX-2006 significantly inhibits the emergence of resistant cells. Chronic exposure to escalating doses of CNX-2006 fails to select for and/or enhance T790M-mediated resistance using PC-9 or HCC827 cells (both harboring exon 19 deletions), or PC-9/ER and HCC827/ER cells with existing T790M and resistance to erlotinib.
  • 體內(nèi)研究:
    CNX-2006 is effective in H1975 (EGFR L858R/T790M) xenograft model.
  • 細(xì)胞實驗: Cells with endogenous or transiently transfected mutant EGFRs (293 cells) are treated with inhibitors for 6 hours and then corresponding lysates are extracted and analyzed by immunoblotting.(Only for Reference)
  • 動物實驗: Animal Models: Nude miceFormulation: 5% DMSO:15% Solutol HS15 in PBSDosages: 25 mg/kgAdministration: i.p.
  • 參考文獻(xiàn):
    1. Ohashi K, et al. 2013
  • 溶解性: soluble  in  DMSO、DMF
  • 保存條件: -20°C
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.833 ml 9.165 ml 18.331 ml
    5 mM 0.367 ml 1.833 ml 3.666 ml
    10 mM 0.183 ml 0.917 ml 1.833 ml
    50 mM 0.037 ml 0.183 ml 0.367 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。